CONCENTRATION OF RISKS (Details 1) - USD ($)	3 Months Ended		9 Months Ended
CONCENTRATION OF RISKS (Details 1) - USD ($)	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Concentration of risk purchase	$ 1,018,438	$ 1,320,382	$ 2,434,197	$ 3,096,774
Percentage of purchases	47.02%	57.30%	41.59%	51.56%
Accounts payable trade	$ 94,145	$ 808,423	$ 94,145	$ 808,423
Vendor D [Member]
Concentration of risk purchase	$ 0	$ 347,281
Percentage of purchases	0.00%	15.07%
Accounts payable trade	$ 0	$ 313,016
Vendor A [Member]
Concentration of risk purchase	$ 407,648	$ 386,895	$ 1,494,227	$ 1,058,928
Percentage of purchases	18.82%	16.79%	25.53%	17.63%
Accounts payable trade	$ 0	$ 317,624	$ 0	$ 317,624
Vendor B [Member]
Concentration of risk purchase	$ 380,771	$ 586,206	$ 939,970	$ 1,069,272
Percentage of purchases	17.58%	25.44%	16.06%	17.80%
Accounts payable trade	$ 94,145	$ 177,783	$ 94,145	$ 177,738
Vendor C [Member]
Concentration of risk purchase	$ 230,019	$ 0	$ 0	$ 968,574
Percentage of purchases	10.62%	0.00%	0.00%	16.13%
Accounts payable trade	$ 0	$ 0	$ 0	$ 313,016

BioNexus Gene Lab Corp 10-Q